Timothy M Fan

Timothy M Fan is a Professor at the University of Illinois Urbana-Champaign, holding academic positions in Veterinary Clinical Medicine, Veterinary Teaching Hospital, Pathobiology, Biomedical and Translational Sciences, and the Carl R. Woese Institute for Genomic Biology. He also serves as the Assistant Head for Research and Graduate Studies in Veterinary Clinical Medicine and Director of the Veterinary Clinical Trials Center. His leadership roles include Associate Director for Development and Translation at the Cancer Center at Illinois and Program Leader in the same center. Additionally, he holds an adjunct professorship in Comparative Biosciences.

Dr. Fan’s research focuses on translational oncology, immunotherapy, and molecular pharmacology, with a strong emphasis on veterinary medicine applications. He has pioneered studies on cancer therapies using small molecules and immunomodulatory agents, including preclinical trials in canine models. His work on therapies like PAC-1 and ErSO demonstrates advancements in synergistic drug combinations and tumor regression mechanisms. Notably, his contributions to the SHIELD program highlight his role in pandemic management strategies combining testing and modeling.

His recent publications (2024–2025) explore innovative cancer treatments, including complete tumor regressions in mouse models and immunotherapy strategies for malignant melanoma in dogs. These studies underscore his interdisciplinary approach, bridging veterinary science, pharmacology, and molecular biology. Despite no listed awards, his multiple patents (e.g., U.S. Patent 12234240) reflect significant contributions to drug development. His advisory roles and grants are central to his role in advancing translational research across multiple university institutes.

Dr. Fan’s work integrates clinical trials, basic science, and biomedical innovation through affiliations with the Veterinary Clinical Trials Center and the Cancer Center at Illinois. His research environment emphasizes collaborative, team-based science with a focus on high-impact translational outcomes.